| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 97.46B | 96.19B | 93.06B | 85.06B | 78.45B | 71.97B |
| Gross Profit | 46.14B | 42.52B | 40.55B | 35.44B | 34.96B | 31.64B |
| EBITDA | 10.10B | 9.52B | 8.96B | 4.24B | 7.53B | 5.35B |
| Net Income | 3.55B | 3.15B | 2.57B | -318.00M | 3.42B | 997.00M |
Balance Sheet | ||||||
| Total Assets | 79.21B | 80.58B | 79.71B | 75.11B | 70.15B | 64.83B |
| Cash, Cash Equivalents and Short-Term Investments | 24.84B | 26.02B | 23.57B | 19.58B | 20.69B | 14.26B |
| Total Debt | 4.92B | 4.71B | 6.45B | 6.87B | 3.99B | 4.35B |
| Total Liabilities | 24.22B | 26.25B | 27.62B | 27.01B | 21.57B | 19.49B |
| Stockholders Equity | 54.73B | 54.05B | 51.83B | 47.86B | 48.32B | 45.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.08B | 6.40B | -1.84B | 8.48B | 3.10B |
| Operating Cash Flow | 0.00 | 7.35B | 10.16B | 1.42B | 10.45B | 4.40B |
| Investing Cash Flow | 0.00 | -1.64B | -2.13B | -2.97B | -798.00M | 45.00M |
| Financing Cash Flow | 0.00 | -3.73B | -3.94B | 611.00M | -3.83B | -2.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥1.04T | 25.06 | 13.08% | 0.76% | 2.73% | 18.30% | |
70 Outperform | ¥128.73B | 20.09 | ― | 0.70% | 5.15% | 47.13% | |
63 Neutral | ¥770.78B | 45.71 | 9.53% | 0.55% | 15.58% | 60.90% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥1.49T | 28.68 | 15.36% | 0.78% | 11.29% | -4.88% | |
53 Neutral | ¥379.15B | 34.66 | ― | 0.24% | 9.19% | 43.90% | |
53 Neutral | ¥210.56B | 72.52 | ― | 0.69% | 10.75% | -14.28% |